Patrick Bilbo serves as the Chief Operating Officer at Organogenesis Holdings Inc Class A, a leading regenerative medicine company focused on developing and commercializing solutions for the advanced wound care, surgical, and sports medicine markets. In his role, Bilbo is responsible for overseeing the company's day-to-day operations, ensuring the efficient and effective execution of its strategic initiatives, and driving the organization's overall performance. With his extensive experience in the life sciences industry, Bilbo plays a crucial role in guiding Organogenesis towards its mission of providing innovative solutions that improve patients' lives. Prior to joining Organogenesis, Bilbo held several leadership positions in the healthcare and biotechnology sectors. He has a proven track record of successfully managing complex operations, implementing process improvements, and leading cross-functional teams to achieve organizational goals. Bilbo's expertise in operational excellence, quality management, and regulatory compliance has been instrumental in helping Organogenesis maintain its position as a pioneer in the regenerative medicine field. Under his leadership, the company has been able to scale its manufacturing capabilities, streamline its supply chain, and enhance its overall operational efficiency, ultimately contributing to the company's growth and success. As the Chief Operating Officer, Bilbo works closely with the executive team to develop and execute Organogenesis' long-term strategic plan. He is committed to fostering a culture of innovation, collaboration, and continuous improvement within the organization. Bilbo's leadership and vision have been vital in driving the company's efforts to expand its product portfolio, enter new markets, and strengthen its position as a leader in the regenerative medicine industry. With his extensive knowledge and experience, Bilbo continues to play a pivotal role in shaping the future of Organogenesis and advancing the field of regenerative medicine.